{"url_path":"/sec/carl/8-k/2026-06-03/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1794546/0001193125-26-255404-index.html","accession_number":"0001193125-26-255404","cik":"0001794546","ticker":"CARL","issuer_name":"CARLSMED, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1794546/0001193125-26-255404-index.html","primary_entity_key":"0001794546","primary_entity_name":"CARLSMED, INC."},"word_count":220,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nCarlsmed, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on June 3, 2026. At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 22, 2026. The vote totals noted below are final voting results from the Annual Meeting.\n\n \n\nProposal 1\n\nThe Company’s stockholders elected the following two Class I directors to serve on the Company’s board of directors until the 2029 annual meeting of stockholders, or until their successors are duly elected and qualified.\n\n \n\n \n\nName\n\n \n\nVotes For\n\n \n\n \n\nVotes Withheld\n\n \n\n \n\nBroker Non-Votes\n\n \n\nNiall Casey\n\n \n\n \n\n19,627,716\n\n \n\n \n\n \n\n1,352,117\n\n \n\n \n\n \n\n4,628,080\n\n \n\nPhilip Young\n\n \n\n \n\n19,510,686\n\n \n\n \n\n \n\n1,469,147\n\n \n\n \n\n \n\n4,628,080\n\n \n\n \n\nProposal 2\n\nThe Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.\n\n \n\n \n\nVotes For\n\n \n\n \n\nVotes Against\n\n \n\n \n\nAbstentions\n\n \n\n \n\n25,571,065\n\n \n\n \n\n \n\n5,858\n\n \n\n \n\n \n\n30,990\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDate: June 3, 2026\n\n \n\nCarlsmed, Inc.\n\n \n\n \n\n \n\n \n\n \n\n \n\nBy:\n\n/s/ Michael Cordonnier\n\n \n\n \n\n \n\nMichael Cordonnier\n\n \n\n \n\n \n\nChief Executive Officer and President"}